Notice2026-03978
Prospective Grant of an Exclusive Patent License: In Vivo Manufactured Anti-CD19 Chimeric Antigen Receptor (CAR) Products for the Treatment or Prevention of B Cell Mediated Autoimmune Diseases; Correction
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 27, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The Department of Health and Human Services, National Institutes of Health published a Notice in the Federal Register on February 20, 2025. That notice requires a correction in the SUMMARY section.
Indexed from Federal Register on February 27, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.